Clinical trial

RC48-ADC in HER2-low Advanced Breast Cancer

NCT05831878

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-05-04

PhaseNA

Study timeline

Study start (actual)2023-05-04Date precision: day

Registry last updated2026-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Breast Cancerunresolved

Interventions

Disitamab vedotinDRUG

Sponsors & collaborators

RenJi Hospitallead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05831878 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.